Avanza Fonder AB Buys 7,149 Shares of CVS Health Corporation $CVS

Avanza Fonder AB grew its stake in CVS Health Corporation (NYSE:CVS) by 7.5% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 102,631 shares of the pharmacy operator’s stock after buying an additional 7,149 shares during the period. Avanza Fonder AB’s holdings in CVS Health were worth $8,145,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Norges Bank bought a new position in shares of CVS Health during the 2nd quarter valued at approximately $1,358,698,000. Wellington Management Group LLP lifted its holdings in CVS Health by 391.6% during the third quarter. Wellington Management Group LLP now owns 6,330,717 shares of the pharmacy operator’s stock valued at $477,273,000 after purchasing an additional 5,042,816 shares in the last quarter. Amundi boosted its position in shares of CVS Health by 95.3% in the third quarter. Amundi now owns 7,453,980 shares of the pharmacy operator’s stock worth $572,665,000 after purchasing an additional 3,637,943 shares during the period. Invesco Ltd. boosted its position in shares of CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after purchasing an additional 3,118,626 shares during the period. Finally, Capital Research Global Investors increased its stake in shares of CVS Health by 24.5% in the third quarter. Capital Research Global Investors now owns 11,469,250 shares of the pharmacy operator’s stock worth $864,667,000 after purchasing an additional 2,253,531 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on CVS. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Mizuho raised their price target on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. TD Cowen restated a “buy” rating on shares of CVS Health in a research report on Friday, March 13th. Barclays upped their price objective on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Finally, Leerink Partners reissued an “outperform” rating and set a $98.00 target price on shares of CVS Health in a research note on Thursday, March 5th. Twenty research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $95.05.

CVS Health Stock Performance

NYSE CVS opened at $71.26 on Tuesday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15. The business has a 50 day simple moving average of $77.30 and a two-hundred day simple moving average of $77.82. The stock has a market capitalization of $90.66 billion, a PE ratio of 51.64, a P/E/G ratio of 0.75 and a beta of 0.49.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same period in the prior year, the company earned $1.19 EPS. The company’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date of this dividend is Thursday, April 23rd. CVS Health’s dividend payout ratio (DPR) is presently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.